NASH: prevalence and incidence of non-liver comorbidities in South Korea

Using a meta-analytic approach, J. Park et al. (Santa Clara Valley Medical Center, San Jose, CA, USA) aimed to describe NAFLD incidence and prevalence, NAFLD fibrosis prevalence, and incidence of non-liver comorbidities. In this study, the overall prevalence of NAFLD was 31.46% with an incidence rate of 42.8 per 1,000 person-years...
PUBLISHED IN: Dig Dis 2021

Commentary

Using a meta-analytic approach, J. Park et al. (Santa Clara Valley Medical Center, San Jose, CA, USA) aimed to describe NAFLD incidence and prevalence, NAFLD fibrosis prevalence, and incidence of non-liver comorbidities.

In this study, the overall prevalence of NAFLD was 31.46% with an incidence rate of 42.8 per 1,000 person-years, and NASH prevalence was 52%. The prevalence and incidence of non-liver comorbidities was high especially for cardiovascular disease incidence.

Share the article
Dr. D. Beard

Dr. D. Beard

Articles: 207

Leave a Reply

Your email address will not be published.